Solaris Endovascular Inc.

New Filing
CIK: 0002156481·Biotechnology·DELAWARE·Filed: Oct 1, 2026
Total Offering

$10,000,000

Amount Sold

$4,972,500

Investors

45

First Sale

Sep 5, 2025

Offering Details

Type
Equity, Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Randolph W. Hubbell
Related Person
Alexander Marra Moreira
Related Person
Melchiades de Cunha Neto
Related Person
Marco Costa
Related Person
David Stack
Related Person
Matthew Head
Related Person

Company

Solaris Endovascular Inc.

3232 MCKINNEY AVENUE

DALLAS, TX, 75204

215-688-6196

SEC Filing

0002156481-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free